PATENT CLAIM ANALYSIS

Application Number: 15982141
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Claim (Index 16):
The method of  claim 15 , wherein the cancer is selected from the group consisting of brain cancer, lung cancer, breast cancer, oral cancer, esophageal cancer, stomach cancer, liver cancer, bile duct cancer, pancreatic cancer, colon cancer, kidney cancer, bone cancer, skin cancer, cervical cancer, ovarian cancer, and prostate cancer.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15011544', '15011543', '14798312', '14599174', '15683685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7923964110633119
- 35 USC 102 Novelty (BERT): 0.6082948916354879
- Combined Prediction Score: 0.7739862591205295
- Mean Citation Score: 611.699212
- Max Citation Score: 860.38965
- Similarity Product: 492.7159414690912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test